RedHill Biopharma (RDHL) Cost of Revenue (2014 - 2023)
RedHill Biopharma (RDHL) reported Cost of Revenue of $1.98 million for the year ended Dec 31, 2025, down 38.1% from $3.19 million a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Cost of Revenue (2014 - 2023) Analysis & Trends
Dating back to the year ended Dec 31, 2014, RedHill Biopharma's Cost of Revenue record includes 10 years.
- Cost of Revenue has declined for four consecutive years, with a five-year compound annual growth rate of -44.3% (years ended Dec 2020 to Dec 2025).
- The figure for the year ended Dec 31, 2025 ranks as the lowest annual Cost of Revenue since the year ended Dec 31, 2014.
- According to Business Quant data, Cost of Revenue came in at $3.19 million in the year ended Dec 31, 2024 (-7.7%), $3.46 million in the year ended Dec 31, 2023 (-89.6%), $33.34 million in the year ended Dec 31, 2022 (-32.5%) and $49.41 million in the year ended Dec 31, 2021 (+33.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 4.09 Bn |
| 10 | RedHill Biopharma | 2.14 Mn | -14.47 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 806,000.00 |
| Mar 31, 2023 | 1.61 Mn |
| Dec 31, 2022 | 8.60 Mn |
| Sep 30, 2022 | 9.45 Mn |
| Jun 30, 2022 | 9.00 Mn |
| Mar 31, 2022 | 6.29 Mn |
| Dec 31, 2021 | 19.33 Mn |
| Sep 30, 2021 | 9.23 Mn |
| Jun 30, 2021 | 10.59 Mn |
| Mar 31, 2021 | 10.25 Mn |
| Dec 31, 2020 | 10.65 Mn |
| Sep 30, 2020 | 10.34 Mn |
| Jun 30, 2020 | 14.19 Mn |
| Mar 31, 2020 | 1.72 Mn |
| Dec 31, 2019 | 788,000.00 |
| Sep 30, 2019 | 629,000.00 |
| Jun 30, 2019 | 425,000.00 |
| Mar 31, 2019 | 417,000.00 |
| Dec 31, 2018 | 584,000.00 |
| Sep 30, 2018 | 598,000.00 |
API Access
RedHill Biopharma Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();